Globally, drugmakers are expected to increase second-quarter earnings per share by 2%, after they rose 17% in the first quarter, according to Cowen & Co.
Pfizer, which has released early data on its vaccine candidate being developed with German biotech BioNTech SE , will kick off the week of drugmaker earnings on Tuesday morning. Gilead’s antiviral treatment, remdesivir, has become a key weapon for many countries after the intravenously administered medicine helped shorten hospital recovery times in a U.S. trial.
Well, I never expected that ! 🤑
Hey Democrats! Here, money to redistribute! *crickets*
Don’t need it, Doc on steps has a cure.
Sverige Senaste nytt, Sverige Rubriker
Similar News:Du kan också läsa nyheter som liknar den här som vi har samlat in från andra nyhetskällor.
US stocks rise as tech trades higher, investors await stimulus bill | Markets InsiderUS stocks rose on Monday as investors looked to major earnings on deck this week and awaited the release of the GOP's coronavirus stimulus plan.... Meanwhile, their customers are getting screwed.
Läs mer »